Mizuho Cuts Adverum Biotechnologies Price Target to 22.00 - MarketBeat Mizuho Cuts Adverum Biotechnologies Price Target to 22.00 MarketBeat

Mizuho Cuts Adverum Biotechnologies Price Target to 22.00 - MarketBeat

ADVM Stock  USD 2.23  0.27  10.80%   
About 58% of all Adverum Biotechnologies' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Adverum Biotechnologies suggests that some traders are interested. Adverum Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Adverum Biotechnologies. Many technical investors use Adverum Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Mizuho Cuts Adverum Biotechnologies Price Target to 22.00 MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Adverum Biotechnologies Current Investor Sentiment

Comfort Level 58

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Adverum Biotechnologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Adverum Biotechnologies.

Adverum Biotechnologies Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Adverum Biotechnologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Adverum Biotechnologies Historical Investor Sentiment

Investor biases related to Adverum Biotechnologies' public news can be used to forecast risks associated with an investment in Adverum. The trend in average sentiment can be used to explain how an investor holding Adverum can time the market purely based on public headlines and social activities around Adverum Biotechnologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Adverum Biotechnologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adverum Biotechnologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Adverum Biotechnologies news discussions. The higher the estimate score, the more favorable the investor's outlook on Adverum Biotechnologies.

Adverum Biotechnologies Fundamental Analysis

We analyze Adverum Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Adverum Biotechnologies is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Adverum Biotechnologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adverum Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with similar companies.

Peers

Adverum Biotechnologies Related Equities

PASGPassage Bio   16.27   
0%
100.0%
SLDBSolid Biosciences   7.04   
0%
43.0%
GLMDGalmed Pharmaceuticals   2.92   
0%
17.0%
ANTXAN2 Therapeutics   1.71   
0%
10.0%
KODKodiak Sciences   0.28   
0%
1.0%
ADAGAdagene   0.00   
0%
0%
RCKTRocket Pharmaceuticals   0.46   
2.0%
0%
RYTMRhythm Pharmaceuticals   0.64   
3.0%
0%
MREOMereo BioPharma   0.87   
5.0%
0%
ABSIAbsci Corp   1.48   
9.0%
0%
QUREUniqure NV   1.74   
10.0%
0%
KZRKezar Life   2.68   
16.0%
0%
RZLTRezolute   2.74   
16.0%
0%
MGTXMeiraGTx Holdings   4.53   
27.0%
0%
STOKStoke Therapeutics   5.47   
33.0%
0%
ACRVAcrivon Therapeutics,   8.00   
49.0%
0%
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Adverum Biotechnologies Hype Analysis, Adverum Biotechnologies Correlation and Adverum Biotechnologies Performance.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.22)
Revenue Per Share
0.048
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.49)
Return On Equity
(1.45)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.